West Pharmaceutical
About: West Pharmaceutical Services is based in Pennsylvania, US, and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs, which include large molecule biologics, peptides such as GLP-1 receptor agonists, and small molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.
Employees: 10,600
Fund manager confidence
Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)
150% more funds holding in top 10
Funds holding in top 10: 4 [Q3] → 10 (+6) [Q4]
32% more first-time investments, than exits
New positions opened: 103 | Existing positions closed: 78
14% more repeat investments, than reductions
Existing positions increased: 289 | Existing positions reduced: 254
13% more capital invested
Capital invested by funds: $20.2B [Q3] → $22.8B (+$2.57B) [Q4]
2.73% more ownership
Funds ownership: 93.28% [Q3] → 96.01% (+2.73%) [Q4]
2% more funds holding
Funds holding: 720 [Q3] → 732 (+12) [Q4]
44% less call options, than puts
Call options by funds: $77.4M | Put options by funds: $139M
Research analyst outlook
2 Wall Street Analysts provided 1 year price targets over the past 3 months
2 analyst ratings
Evercore ISI Group Daniel Markowitz 0% 1-year accuracy 0 / 2 met price target | 26%upside $275 | Outperform Initiated | 18 Mar 2025 |
Keybanc Paul Knight 0% 1-year accuracy 0 / 9 met price target | 49%upside $325 | Overweight Maintained | 14 Feb 2025 |
Financial journalist opinion
Based on 24 articles about WST published over the past 30 days









